Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interchangeability Study of SB5 vs Humira in Plaque Psoriasis
NCT05510063Phase 4Completed
- Sponsor
- Samsung Bioepis
- Start
- Aug 2022
- Primary completion
- Apr 2023
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 4 trial of adalimumab in plaque psoriasis, sponsored by Samsung Bioepis. Started Aug 2022; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05510063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05510063.